Terzolo M - Search Results

1

Metronomic therapy concepts in the management of adrenocortical carcinoma.

Berruti A, Sperone P, Bellini E, Daffara F, Perotti P, Ardito A, Saini A, Terzolo M. Berruti A, et al. Among authors: terzolo m. Horm Cancer. 2011 Dec;2(6):378-84. doi: 10.1007/s12672-011-0087-1. Horm Cancer. 2011. PMID: 21971765 Free PMC article. Review.

2

Favorable response of metastatic adrenocortical carcinoma to etoposide, adriamycin and cisplatin (EAP) chemotherapy. Report of two cases.

Berruti A, Terzolo M, Paccotti P, Veglio F, Pia A, Dogliotti L, Angeli A. Berruti A, et al. Among authors: terzolo m. Tumori. 1992 Oct 31;78(5):345-8. doi: 10.1177/030089169207800512. Tumori. 1992. PMID: 1494808

3

Feasibility of the association of mitotane with etoposide, adriamycin and cisplatin combination chemotherapy in advanced adrenocortical cancer patients. Report on 7 cases.

Pia A, Berruti A, Terzolo M, Paccotti P, Letizia C, Dogliotti L, Angeli A. Pia A, et al. Among authors: terzolo m. Ann Oncol. 1995 May;6(5):509-10. doi: 10.1093/oxfordjournals.annonc.a059224. Ann Oncol. 1995. PMID: 7669716 Free article. Clinical Trial. No abstract available.

4

Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.

Berruti A, Terzolo M, Pia A, Angeli A, Dogliotti L. Berruti A, et al. Among authors: terzolo m. Cancer. 1998 Nov 15;83(10):2194-200. Cancer. 1998. PMID: 9827725 Clinical Trial.

5

Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer.

Terzolo M, Pia A, Berruti A, Osella G, Alì A, Carbone V, Testa E, Dogliotti L, Angeli A. Terzolo M, et al. J Clin Endocrinol Metab. 2000 Jun;85(6):2234-8. doi: 10.1210/jcem.85.6.6619. J Clin Endocrinol Metab. 2000. PMID: 10852456

6

Ectopic ACTH syndrome: molecular bases and clinical heterogeneity.

Terzolo M, Reimondo G, Alì A, Bovio S, Daffara F, Paccotti P, Angeli A. Terzolo M, et al. Ann Oncol. 2001;12 Suppl 2:S83-7. doi: 10.1093/annonc/12.suppl_2.s83. Ann Oncol. 2001. PMID: 11762358 Free article. Review.

7

Adrenal incidentaloma: a new cause of the metabolic syndrome?

Terzolo M, Pia A, Alì A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A. Terzolo M, et al. J Clin Endocrinol Metab. 2002 Mar;87(3):998-1003. doi: 10.1210/jcem.87.3.8277. J Clin Endocrinol Metab. 2002. PMID: 11889151

8

The neoplastic complications of acromegaly.

Terzolo M, Daffara F, Reimondo G, Allasino B, Ventura M, Angeli A. Terzolo M, et al. J Endocrinol Invest. 2003;26(8 Suppl):32-4. J Endocrinol Invest. 2003. PMID: 15233209 Review. No abstract available.

9

Hyperhomocysteinemia in patients with Cushing's syndrome.

Terzolo M, Allasino B, Bosio S, Brusa E, Daffara F, Ventura M, Aroasio E, Sacchetto G, Reimondo G, Angeli A, Camaschella C. Terzolo M, et al. J Clin Endocrinol Metab. 2004 Aug;89(8):3745-51. doi: 10.1210/jc.2004-0079. J Clin Endocrinol Metab. 2004. PMID: 15292300

10

Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy.

Terzolo M, Reimondo G, Gasperi M, Cozzi R, Pivonello R, Vitale G, Scillitani A, Attanasio R, Cecconi E, Daffara F, Gaia E, Martino E, Lombardi G, Angeli A, Colao A. Terzolo M, et al. J Clin Endocrinol Metab. 2005 Jan;90(1):84-90. doi: 10.1210/jc.2004-0240. Epub 2004 Oct 26. J Clin Endocrinol Metab. 2005. PMID: 15507515

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

285 results

Search Page

Filters